An analysis of RNA quality metrics in human brain tissue
Journal of Neuropathology & Experimental Neurology · 21.02.2025 · 84 (3) · 236-243
DOI: 10.1093/jnen/nlae132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, online erschienen am 23.12.2024. Verfasst von Jiahe Tian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States. Hauptthemen laut MEDLINE: Brain, RNA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Thompson Family Foundation.
Abstract (Originalsprache)
Human brain tissue studies have used a range of metrics to assess RNA quality but there are few large-scale cross-comparisons of presequencing quality metrics with RNA-seq quality. We analyzed how postmortem interval (PMI) and RNA integrity number (RIN) before RNA-seq relate to RNA quality after sequencing (percent of counts in top 10 genes [PTT], 5′ bias, and 3′ bias), and with individual gene counts across the transcriptome. We analyzed 4 human cerebrocortical tissue sets (1 surgical, 3 autopsy), sequenced with varying protocols. Postmortem interval and RIN had a low inverse correlation (down to r = −0.258, P < .001 across the autopsy cohorts); both PMI and RIN showed consistent and opposing correlations with PTT (up to r = 0.215, P < .001 for PMI and down to r = −0.677, P < .001 for RIN across the autopsy cohorts). Unlike PMI, RIN showed consistent correlations with measurements of 3′ and 5′ bias in autopsies (r = −0.366, P < .001 with 3′ bias). RNA integrity number correlated with 3933 genes across the 4 datasets vs 138 genes for PMI. Neuronal and immune response genes correlated positively and negatively with RIN, respectively. Thus, different gene sets have divergent relationships with RIN. These analyses suggest that conventional metrics of RNA quality have varying values and that PMI has an overall modest effect on RNA quality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, United States.
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, United States.
- Department of Neurology, Columbia University Irving Medical Center, New York, NY, United States.
- Department of Neurosurgery, Columbia University Irving Medical Center, New York, NY, United States.
- New York Genome Center, New York, NY, United States.
ORCID-Profile: Andrew F Teich
Förderung
- NIA NIH HHS
- NIH HHS
- Thompson Family Foundation
- NIH
Zitieren
APA
Tian, J., Lam, T. G., Ross, S. K., Ciener, B., Leskinen, S., Sivakumar, S., Bennett, D. A., Menon, V., McKhann, G. M., Runnels, A., & Teich, A. F. (2025). An analysis of RNA quality metrics in human brain tissue. Journal of Neuropathology & Experimental Neurology, 84(3), 236-243. https://doi.org/10.1093/jnen/nlae132
Vancouver
Tian J, Lam TG, Ross SK, Ciener B, Leskinen S, Sivakumar S, et al. An analysis of RNA quality metrics in human brain tissue. Journal of Neuropathology & Experimental Neurology. 2025;84(3):236-243. doi:10.1093/jnen/nlae132
BibTeX
@article{Tian2025,
author = {Tian, Jiahe and Lam, Tiffany G and Ross, Sophie K and Ciener, Benjamin and Leskinen, Sandra and Sivakumar, Sharanya and Bennett, David A and Menon, Vilas and McKhann, Guy M and Runnels, Alexi and Teich, Andrew F},
title = {An analysis of RNA quality metrics in human brain tissue},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2025},
volume = {84},
number = {3},
pages = {236--243},
doi = {10.1093/jnen/nlae132}
}
EUVIMED